Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation

Molecular and Cellular Biology

Volumn 20, Issue 22, 2000, Pages 8458-8467

  Rodriguez, M S ^a   Desterro, J M P ^a   Lain, S ^a   Lane, D P ^a   Hay, R T ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LYSINE; PROTEASOME; PROTEIN P53; UBIQUITIN; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN TARGETING; WART VIRUS;

AMINO ACID SUBSTITUTION; ANIMALS; CELL LINE; CYSTEINE ENDOPEPTIDASES; GENE EXPRESSION REGULATION; HUMANS; LYSINE; MICE; MULTIENZYME COMPLEXES; MUTATION; NUCLEAR PROTEINS; ONCOGENE PROTEINS, VIRAL; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; REPRESSOR PROTEINS; SUBCELLULAR FRACTIONS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITINS;

EID: 0033767235     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.22.8458-8467.2000     Document Type: Article

References (66)

1. The specificity of the CRM1-Rev nuclear export signal interaction is mediated by RanGTP
2. Critical role for lysine-21 and lysine-22 signal-induced, ubiquitin-mediated proteolysis of IκBα
3. mdm2 expression is induced by wild type p53 activity
4. Identification of novel mdm2 binding peptides by phage display
5. Mapping of the p53 and mdm-2 interaction domains
6. Sensitivity of p53 lysine mutants to ubiquitin-directed degradation targeted by human papillomavirus E6
7. Nuclear and nucleolar targeting sequences of c-erb-A, c-myb, N-myc, p53, HSP70, and HIV tat proteins
8. SUMO-1 modification of IκBα inhibits NF-κB activation
9. Direct involvement of p53 in programmed cell death of oligodendrocytes
10. WAF1, a potential mediator of p53 tumor suppression
11. CRM1 is an export receptor for leucine-rich nuclear export signals
12. Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6
13. Mdm2 association with p53 targets its ubiquitination
14. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1
15. Identification of a sequence element from p53 that signals for Mdm2-targeted degradation
16. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain
17. Association of casein kinase II with immunopurified p53
18. The ubiquitin system for protein degradation
19. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
20. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53
21. RB regulates the stability and the apoptotic function of p53 via MDM2
22. Allosteric activation of latent p53 tetramers
23. Regulation of the specific DNA binding function of p53
24. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53
25. Participation of p53 protein in the cellular response to DNA damage
26. p53: Puzzle and paradigm
27. The carboxy-terminus of 1κBα determines susceptibility to degradation by the catalytic core of the proteasome
28. Regulation of Mdm2-directed degradation by the C terminus of p53
29. An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs
30. Awakening angels
31. Cancer. p53, guardian of the genome
32. p53, the cellular gatekeeper for growth and division
33. Cooperation of a single lysine mutation and a C-terminal domain in the cytoplasmic sequestration of the p53 protein
34. In-vivo ubiquitination and proteasome-mediated degradation of p53
35. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells
36. The domain of p53 required for binding HPV 16 E6 is separable from the degradation domain
37. Mdm-2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53
38. The p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II
39. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo
40. Analysis of p53 expression in human tumours: An antibody raised against human p53 expressed in Escherichia coli
41. p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding
42. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
43. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
44. Amplification of a gene encoding a p53-associated protein in human sarcomas
45. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
46. Evidence for a role of CRM1 in signal-mediated nuclear protein export
47. The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots
48. PEST sequences and regulation by proteolysis
49. SUMO-1 modification activates the transcriptional response of p53
50. Inducible degradation of IκBα in vitro and in vivo requires the acidic C-terminal domain of the protein
51. Identification of lysine residues required for signal-induced ubiquitination and degradation of IκBα in vivo
52. Amino acid sequences common to rapidly degraded proteins: The PEST hypothesis
53. Reconstitution of p53-ubiquitinylation reactions from purified components - The role of human ubiquitin-conjugating enzyme Ubc4 and E6-associated protein (E6AP)
54. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein
55. DNA damage activates p53 through a phosphorylation-acetylation cascade
56. Signal-induced degradation of IκBα requires site-specific ubiquitination
57. Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis
58. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
59. c-Ab1 neutralizes the inhibitory effect of Mdm2 on p53
60. A leucine-rich nuclear export signal in the p53 tetramerization domain: Regulation of subcellular localization and p53 activity by NES masking
61. Ubiquitin-dependent c-jun degradation in-vivo is mediated by the delta-domain
62. Nuclear export receptors: From importin to exportin
63. Conformational changes in p53 analysed using new antibodies to the core DNA binding domain of the protein
64. Nucleolar Arf sequesters Mdm2 and activates p53
65. The p53-mdm-2 autoregulatory feedback loop
66. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53